United States Uterine Fibroid Market MRFR Unleashes the Forecast for 2018 – 2023
Market Overview
Uterine fibroids are the noncancerous growths of the uterus, which
mostly appear during childbearing years. It is the abnormal growth of that gets
developed inside or on the wall of a woman’s uterus. Uterine fibroids is also
known as myomas or leiomyomas. The symptom of uterine fibroids are frequent
urination, constipation, backache, heavy menstrual bleeding, pelvic pressure,
or menstrual periods lasting more than a week. The women with mild symptoms may
go for medical treatments such as hormonal drugs, gonadotropin agonists,
progestin and oral contraceptives. Women with moderate to severe symptoms may
need surgery to treat uterine fibroids. According to the U.S. Department of
Health and Human Services office on Women Health, about 20% to 80% of women
develop fibroids by the age of 50 and nearly 30% will get them at the age of
35. Uterine fibroids are most common in women in their 40s and early 50s.
The United States
Uterine Fibroid market is showing the significant growth; mainly due to change
in lifestyle mainly dietary pattern, growing number of hysterectomy surgeries.
Additionally rising in aging population also leads the Uterine Fibroid market
with in this region.
United States Uterine Fibroid Market Drivers:
AstraZeneca (U.K),
Cook Medical Inc. (U.S.), Boston Scientific Corporation (U.S.), GE Healthcare
(U.K), AbbVie Inc. (U.S.), Hologic (U.S.), CooperSurgical Inc. (U.S.), C. R.
Bard, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), and Bayer AG
(Germany) are some of the leading players at the cutting edge of the
competition in the market of Uterine Fibroid.
Browse Complete Premium Research Report https://www.marketresearchfuture.com/reports/uterine-fibroid-market-2394
United
States Uterine Fibroid Market -
Regional Analysis
The
market of Uterine Fibroid devices is much higher in the United States region,
owing to its high prevalence in African- American race, change in lifestyle.
According to one large cohort study of NIS on African-American women in
Maryland, uterine fibroids was the cause of 65.4% of total 53,000 women
undergoing hysterectomy.
Moreover,
most of the major market players belong from this region, thus they introduce
the advance technology firstly in the United States in comparison to others
region.
About Market Research
Future: MRFR team have
supreme objective to provide the optimum quality market research and
intelligence services to our clients. In order to stay updated with technology
and work process of the industry, MRFR often plans & conducts meet with the
industry experts and industrial visits for its research analyst members.
Contact:
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar, Pune
+1 646 845 9312
Email: sales@marketresearchfuture.com
Comments
Post a Comment